Publications by authors named "N J Liptrott"

Endotoxin contamination is a significant hurdle to the translation of nanomaterials for biomedical applications. Multiple reports now describe that more than one-third of nanomaterials fail early pre-clinical assessment due to levels of endotoxin above regulatory requirements. Additionally, most immunological studies or studies testing nanomaterials in the literature lack inclusion of this assessment, which may lead to false-positive or false-negative results if high levels of the contaminant are present.

View Article and Find Full Text PDF

Macrophages are well known for their involvement in the biocompatibility, as well as biodistribution, of nano(bio)materials. Although there are a number of rodent cell lines, they may not fully recapitulate primary cell responses, particularly those of human cells. Isolation of tissue-resident macrophages from humans is difficult and may result in insufficient cells with which to determine the possible interaction with nano(bio)materials.

View Article and Find Full Text PDF

Objective: The study evaluated physicochemical properties of eight different polymeric nanoparticles (NPs) and their interaction with lung barrier and their suitability for pulmonary drug delivery.

Methods: Eight physiochemically different NPs were fabricated from Poly lactic-co-glycolic acid (PLGA, PL) and Poly glycerol adipate-co-ω-pentadecalactone (PGA-co-PDL, PG) emulsification-solvent evaporation. Pulmonary barrier integrity was investigated using Calu-3 under air-liquid interface.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists have been using special drug-carrier combinations called polymer-drug conjugates for a long time to help deliver tough medicines that don't dissolve well or can be harmful.
  • These combinations can help make medicines work longer in the body and reduce side effects using different ways to give them, like shots or implants.
  • This study looks at a new way to use a medicine called emtricitabine (FTC) by creating special materials that can slowly release it over more than two weeks, which could make treatments better in the future.
View Article and Find Full Text PDF

Mesenchymal stromal cells (MSCs) have been reported to display efficacy in a variety of preclinical models, but without long-term engraftment, suggesting a role for secreted factors, such as MSC-derived extracellular vesicles (EVs). MSCs are known to elicit immunomodulatory effects, an important aspect of which is their ability to affect macrophage phenotype. However, it is not clear if these effects are mediated by MSC-derived EVs, or other factors secreted by the MSCs.

View Article and Find Full Text PDF